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WAY-100635 is widely used in vitro and in vivo as an antagonist of 5-HT
1A
 receptors [1]. In terms of
pharmacological tools and pharmacological investigations, the ideal reference molecule would be highly
selective for its target over other related and non-related targets. However WAY-100635 displays affinity for and
activity at D
4
 dopamine receptors, and that "off-target" activity confounds its use in pharmacological studies,
particularly when both receptors are present [2]. In this context, we carried out various chemical modifications of




 selectivity. An important increase of
selectivity was obtained when the basic side chain of WAY-100635 was replaced by a 4-phenylpiperazine or a
4-phenyl-1,2,3,6-tetrahydropyridine moiety [3]. In contrast, the introduction of nitrogen atoms in the acyl group
decreased the selectivity by reducing the affinity for 5-HT
1A
 receptors, on the one hand, and enhancing the
affinity for D
4 
receptors on the other hand [3].




 selectivity of aza-derivatives, the binding modes of the compounds
were explored by docking analysis on homology models of the two receptors. It appears that the formation of an
additional hydrogen bond within D
4
 receptors could be the key of the decreased selectivity. These results will be
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